Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Magdalena S Willen
Introduction
Magdalena S Willen is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions for treating various diseases, including cancer.
Latest Patents
Magdalena holds a patent for Anti-IL-18BP antibodies. This patent provides antibodies that bind to interleukin-18 binding protein (IL-18BP) and related compositions. These antibodies may be utilized in a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of cancers and other diseases.
Career Highlights
Magdalena is associated with Lassen Therapeutics, Inc., where she continues to advance her research and development efforts. Her dedication to innovation in the field of biotechnology has positioned her as a key figure in her area of expertise.
Collaborations
Throughout her career, Magdalena has collaborated with notable professionals, including Robert A Horlick and Helen Toni Jun. These partnerships have further enhanced her research and contributed to the success of her projects.
Conclusion
Magdalena S Willen's work exemplifies the spirit of innovation in biotechnology. Her contributions, particularly in the development of therapeutic antibodies, are paving the way for new treatments and diagnostic methods.